Datapile · Sector

Biotech funding

$7M raised across 1 disclosed Biotech rounds.

Last updated · May 24, 2026, 5:27 PM UTC · RSS

Total raised
$6.7M
Rounds
1
Countries
1
1 results
Cumulative USD raised · weekly
Geography · click to filter
Loading map…
Country ›United Kingdom ·1
Sector ›AI|Biotech|ClimateTech|ConsumerTech|Crypto|Cybersecurity|DeepTech|Edtech
Round ›Debt|Grant|Pre-Series A|Pre-Series A5|Pre-seed|Private Equity|Private Placement|Seed|Seed and Series A|Series A|Series A1|Series B|Series C|Series D|Series D-2|Series E|Series F
DateCompanyAmountRoundSectorCountryLead investors
May 21, 26Imperagen
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
$6.7MSeedBiotechUnited KingdomPXN Ventures, IQ Capital, Northern Gritstone
Weekly digest

Get the funding terminal in your inbox.

Filtered to your country and sector. One email per week.